nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—Aripiprazole—ADRA1B—polycystic ovary syndrome	0.0268	0.427	CrCbGaD
Vilazodone—Aripiprazole—ADRA1A—polycystic ovary syndrome	0.018	0.287	CrCbGaD
Vilazodone—Trazodone—ADRA1A—polycystic ovary syndrome	0.0179	0.286	CrCbGaD
Vilazodone—HTR1A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000756	0.000807	CbGpPWpGaD
Vilazodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000755	0.000805	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000741	0.000791	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000735	0.000784	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000733	0.000782	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—LHB—polycystic ovary syndrome	0.000729	0.000778	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000725	0.000773	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000724	0.000772	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HSD3B2—polycystic ovary syndrome	0.000713	0.00076	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000711	0.000758	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.0007	0.000747	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000697	0.000744	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000695	0.000742	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000692	0.000739	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKR1C1—polycystic ovary syndrome	0.00069	0.000736	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000689	0.000735	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000687	0.000733	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000685	0.00073	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000683	0.000729	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00068	0.000725	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000678	0.000723	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000674	0.000719	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000674	0.000719	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000673	0.000718	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000672	0.000717	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000667	0.000711	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000666	0.00071	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000664	0.000708	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000659	0.000703	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000658	0.000702	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000655	0.000698	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000651	0.000694	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000645	0.000688	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000644	0.000687	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000639	0.000682	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000639	0.000682	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000636	0.000678	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—SULT2A1—polycystic ovary syndrome	0.000635	0.000678	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000624	0.000666	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000616	0.000657	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—RRM2—polycystic ovary syndrome	0.000615	0.000656	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000612	0.000653	CbGpPWpGaD
Vilazodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000612	0.000653	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000608	0.000648	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000605	0.000645	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000601	0.000641	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000598	0.000638	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000597	0.000637	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000595	0.000635	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—YAP1—polycystic ovary syndrome	0.000593	0.000633	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000591	0.00063	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000586	0.000626	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00058	0.000619	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NAMPT—polycystic ovary syndrome	0.00057	0.000608	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000567	0.000604	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000564	0.000602	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP11A1—polycystic ovary syndrome	0.000563	0.0006	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000561	0.000598	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000561	0.000598	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00055	0.000587	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000541	0.000577	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00054	0.000577	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000536	0.000572	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000536	0.000572	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000534	0.00057	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000533	0.000569	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKR1C3—polycystic ovary syndrome	0.000531	0.000567	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000528	0.000563	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000525	0.00056	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP17A1—polycystic ovary syndrome	0.000523	0.000558	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000513	0.000548	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000509	0.000543	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000501	0.000534	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000499	0.000532	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000497	0.00053	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000495	0.000529	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000483	0.000515	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000468	0.000499	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000458	0.000488	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000456	0.000487	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000455	0.000485	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—TH—polycystic ovary syndrome	0.000453	0.000483	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000451	0.000481	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—SLC2A4—polycystic ovary syndrome	0.00044	0.00047	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00044	0.000469	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00044	0.000469	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000436	0.000465	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00043	0.000459	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000428	0.000456	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000424	0.000452	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000424	0.000452	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000417	0.000445	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000414	0.000442	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP19A1—polycystic ovary syndrome	0.000414	0.000442	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000412	0.000439	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000411	0.000438	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000407	0.000434	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000402	0.000429	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000399	0.000426	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000398	0.000424	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000386	0.000412	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000385	0.000411	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000384	0.00041	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000383	0.000409	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000381	0.000407	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000376	0.000402	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000375	0.000401	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GNAS—polycystic ovary syndrome	0.000369	0.000394	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	0.000366	0.00039	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000364	0.000388	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000364	0.000388	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000361	0.000386	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000357	0.000381	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000357	0.000381	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000355	0.000379	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000354	0.000378	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NCOR1—polycystic ovary syndrome	0.000352	0.000376	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000351	0.000374	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000351	0.000374	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000349	0.000372	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000349	0.000372	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000338	0.000361	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000337	0.00036	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000337	0.000359	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000335	0.000357	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP1A1—polycystic ovary syndrome	0.000334	0.000356	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000331	0.000353	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00033	0.000353	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000327	0.000349	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000326	0.000348	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000326	0.000348	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000325	0.000347	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000321	0.000343	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000319	0.000341	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000314	0.000335	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000312	0.000333	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000311	0.000332	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—polycystic ovary syndrome	0.000311	0.000332	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000306	0.000327	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000296	0.000316	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000292	0.000311	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00029	0.00031	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000289	0.000308	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000286	0.000306	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000286	0.000306	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000277	0.000296	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000277	0.000296	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000274	0.000292	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000273	0.000292	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000269	0.000287	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000269	0.000287	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00026	0.000278	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000259	0.000276	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000256	0.000273	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000256	0.000273	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000254	0.000271	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	0.000252	0.000269	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00025	0.000267	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000249	0.000266	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	0.000249	0.000265	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000249	0.000265	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—INS—polycystic ovary syndrome	0.000247	0.000264	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000244	0.00026	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000236	0.000252	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000236	0.000252	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000236	0.000252	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000236	0.000252	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000235	0.000251	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000234	0.00025	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000232	0.000248	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000227	0.000242	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000226	0.000241	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000225	0.00024	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000222	0.000237	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00022	0.000235	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000219	0.000234	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000218	0.000233	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000217	0.000232	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.00021	0.000224	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.00021	0.000224	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000208	0.000221	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000206	0.00022	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000206	0.00022	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000206	0.00022	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000203	0.000216	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000198	0.000212	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000196	0.00021	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000195	0.000208	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000195	0.000208	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000193	0.000206	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000192	0.000205	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000187	0.0002	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000182	0.000194	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000181	0.000193	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000179	0.000191	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000179	0.000191	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000172	0.000184	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000169	0.000181	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000165	0.000176	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000163	0.000174	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000162	0.000172	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000159	0.00017	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000155	0.000165	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000154	0.000165	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.00015	0.000161	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000145	0.000155	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000144	0.000154	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000142	0.000151	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000142	0.000151	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000141	0.000151	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000139	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	0.000138	0.000147	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000137	0.000147	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000133	0.000142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000133	0.000142	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000132	0.000141	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000127	0.000136	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000127	0.000135	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000127	0.000135	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	0.000126	0.000135	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000126	0.000134	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000122	0.00013	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	0.000121	0.000129	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	0.00012	0.000128	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000119	0.000127	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000117	0.000125	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000117	0.000125	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000117	0.000125	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000114	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000111	0.000119	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	0.000106	0.000113	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000102	0.000109	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	0.000101	0.000108	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	9.84e-05	0.000105	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.25e-05	9.87e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	8.96e-05	9.56e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.72e-05	9.3e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	8.62e-05	9.2e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	8.5e-05	9.07e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	8.45e-05	9.02e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.25e-05	8.81e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	7.86e-05	8.39e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.66e-05	8.17e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.45e-05	7.95e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.95e-05	7.41e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	6.03e-05	6.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.64e-05	6.01e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.56e-05	5.93e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.53e-05	5.9e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	5.3e-05	5.65e-05	CbGpPWpGaD
